2m 2m 2m 2m 2m 2m 2m
UROGEN PHARMA (URGN)
NASDAQ
$39.76+$0.25 (+0.63%)
Price as of Jul 14, 2026 4:40 AM EDT- $1.8BMarket Cap
- 172.67%1-Year Change
- BiotechnologyIndustry
UROGEN PHARMA (URGN)
$39.76+$0.25 (+0.63%)
URGN | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $39.51 | ||
Change | +$0.95 (+2.46%) | ||
Open | $37.87 | ||
High | $40.00 | ||
Low | $36.81 | ||
Previous Close | $38.56 | ||
Volume | 577,266 | ||
30-Day Average Volume | 758,074 | ||
1-Week Change | 5.61% | ||
1-Month Change | 32.94% | ||
1-Year Change | 172.67% | ||
3-Year Change | 339.49% | ||
5-Year Change | 162.18% | ||
Fundamentals | |||
Shares Outstanding | 46.8M | ||
Total Assets | $253.7M | ||
Market Cap | $1.8B | ||
Enterprise Value | $1.9B | ||
Period: QTR TTM FY | |||
Revenue | $51.0M | ||
Net Income | -$23.6M | ||
Free Cash Flow | -$45.4M | ||
EBIT | -$28.3M | ||
EBITDA | -$28.3M | ||
Net Working Capital | $186.8M | ||
EPS | -$0.47 | ||
Enterprise Value/EBITDA | -68 | ||
Enterprise Value/Revenue | 38 | ||
P/B | -15 | ||
P/E | -84 | ||
PEG | -7 | ||
Price/Free Cash Flow | -41 | ||
Price/Operating Cash Flow | -41 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue